Loading...
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CRDL’s FA Score shows that 0 FA rating(s) are green whileETON’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CRDL’s TA Score shows that 4 TA indicator(s) are bullish while ETON’s TA Score has 4 bullish TA indicator(s).
CRDL (@Pharmaceuticals: Other) experienced а +7.61% price change this week, while ETON (@Pharmaceuticals: Other) price change was +20.19% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.19%. For the same industry, the average monthly price growth was -4.43%, and the average quarterly price growth was +19088.38%.
CRDL is expected to report earnings on Aug 13, 2024.
ETON is expected to report earnings on Aug 08, 2024.
Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
CRDL | ETON | CRDL / ETON | |
Capitalization | 124M | 96.3M | 129% |
EBITDA | -30.61M | -291K | 10,520% |
Gain YTD | 134.820 | -14.384 | -937% |
P/E Ratio | N/A | 49.33 | - |
Revenue | 0 | 31.6M | - |
Total Cash | 40.5M | 21.4M | 189% |
Total Debt | 181K | 5.4M | 3% |
CRDL | ETON | |
---|---|---|
RSI ODDS (%) | 2 days ago89% | 2 days ago80% |
Stochastic ODDS (%) | 2 days ago90% | 2 days ago88% |
Momentum ODDS (%) | 2 days ago84% | 2 days ago86% |
MACD ODDS (%) | 2 days ago84% | 2 days ago77% |
TrendWeek ODDS (%) | 2 days ago85% | 2 days ago80% |
TrendMonth ODDS (%) | 2 days ago88% | 2 days ago80% |
Advances ODDS (%) | 3 days ago83% | 2 days ago81% |
Declines ODDS (%) | 5 days ago87% | 9 days ago83% |
BollingerBands ODDS (%) | 2 days ago90% | 2 days ago90% |
Aroon ODDS (%) | 2 days ago88% | 2 days ago83% |
A.I.dvisor tells us that CRDL and PETQ have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CRDL and PETQ's prices will move in lockstep.
Ticker / NAME | Correlation To CRDL | 1D Price Change % | ||
---|---|---|---|---|
CRDL | 100% | -3.88% | ||
PETQ - CRDL | 25% Poorly correlated | -0.18% | ||
SNDL - CRDL | 23% Poorly correlated | +2.25% | ||
FLGC - CRDL | 23% Poorly correlated | -4.09% | ||
ACB - CRDL | 23% Poorly correlated | -5.30% | ||
ETON - CRDL | 22% Poorly correlated | +1.90% | ||
More |